Ranbaxy Fights Doc Bid In Nexium Pay-For-Delay Fight
Generic-drug maker Ranbaxy Inc. on Tuesday told a Massachusetts federal court it did not need to turn over additional documents ahead of a trial in a pay-for-delay multidistrict litigation involving the...To view the full article, register now.
Already a subscriber? Click here to view full article